CN Stock MarketDetailed Quotes

601607 Shanghai Pharmaceuticals Holding

Watchlist
  • 19.36
  • -0.22-1.12%
Not Open Jan 17 15:00 CST
71.79BMarket Cap17.83P/E (TTM)

Shanghai Pharmaceuticals Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Pharmaceuticals Holding Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 76.305B--
--2024/Q4-- / 71.425B--
--2024/Q370.216B / 68.418B--
--2024/Q269.260B / 73.798B--
--2024/Q170.153B / 66.303B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 76.305B--
--2024/Q4-- / 71.425B--
--2024/Q370.216B / 68.418B--
--2024/Q269.260B / 73.798B--
--2024/Q170.153B / 66.303B--

Unlock Free Earnings Estimates

Shanghai Pharmaceuticals Holding Earnings Reports

  • Shanghai Pharmaceutical Group Co., Ltd. Third Quarter Report 2024

    Oct 29, 2024 12:00 ET

  • Full text of the semi-annual report of SH Pharma Group Co., Ltd. for 2024

    Aug 26, 2024 12:00 ET

  • Summary of the semi-annual report of Shanghai Pharma Group Co., Ltd. for the year 2024.

    Aug 26, 2024 12:00 ET

  • Shanghai Pharmaceutical Group Co., Ltd. 2024 First Quarter Report

    Apr 26, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 19, 2025

    Strong Buy

    • Strong Buy

      81.25%

    • Buy

      18.75%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Innovative Drugs
    Innovative Drugs
    Intraday+0.64%
    Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday+0.62%
    Biomedical
    Biomedical
    Intraday+0.46%